ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities

June 27, 1975

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

ACS Awards Medals to Holland, Sporn, RWJ Foundation

December 2, 1994

ASCO Places Ad To Urge Increase In Research Funding.

June 13, 2008